Impact of COVID‐19 in immunosuppressive drug‐naïve autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease
Open Access
- 25 January 2022
- journal article
- research article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 33 (S27) , 105-107
Abstract
Few conflicting data are currently available on the risk of SARS‐CoV‐2 infection in patients with autoimmune disorders. The studies performed so far are influenced, in most cases, by the treatment with immunosuppressive drugs, making it difficult to ascertain the burden of autoimmunity per se. For this reason, herein we assessed the susceptibility to COVID‐19 in immunosuppressive drug‐naïve patients with autoimmune diseases, such as autoimmune gastritis (AIG), celiac disease (CD), type 1 diabetes (T1D), and autoimmune thyroid disease (AITD). Telephone interviews were conducted on 400 patients—100 for each group—in May 2021 by looking at the positivity of molecular nasopharyngeal swabs and/or serology for SARS‐CoV‐2, the need for hospitalization, the outcome, and the vaccination status. Overall, a positive COVID‐19 test was reported in 33 patients (8.2%), comparable with that of the Lombardy general population (8.2%). In particular, seven patients with AIG, 9 with CD, 8 with T1D, and 9 with AITD experienced COVID‐19. Only three patients required hospitalization, none died, and 235 (58.7%) were vaccinated, 43 with AIG, 47 with CD, 91 with T1D, and 54 with AITD. These results seem to suggest that autoimmunity per se does not increase the susceptibility to COVID‐19. Also, COVID‐19 seems to be mild in these patients, as indicated by the low hospitalization rates and adverse outcomes, although further studies are needed to better clarify this issue.Keywords
This publication has 13 references indexed in Scilit:
- The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac DiseaseClinical Gastroenterology and Hepatology, 2021
- Risk of COVID-19 in celiac disease patientsAutoimmunity Reviews, 2020
- COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational studyThe Lancet Rheumatology, 2020
- Covid-19 and autoimmunityAutoimmunity Reviews, 2020
- Autoimmune gastritisNature Reviews Disease Primers, 2020
- SARS-CoV-2 infection among patients with systemic autoimmune diseasesAutoimmunity Reviews, 2020
- Thyroid disease in the time of COVID-19Endocrine, 2020
- Carving out a place for internal medicine during COVID‐19 epidemic in ItalyJournal of Internal Medicine, 2020
- Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyGut, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020